CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 150 filers reported holding CARA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296 | -40.6% | 176 | 0.0% | 0.00% | – |
| Q2 2023 | $498 | -42.4% | 176 | 0.0% | 0.00% | – |
| Q1 2023 | $864 | -66.3% | 176 | -26.4% | 0.00% | -100.0% |
| Q4 2022 | $2,567 | +28.4% | 239 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | 0.0% | 239 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | -33.3% | 239 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $3,000 | -25.0% | 239 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | +33.3% | 239 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $3,000 | -40.0% | 239 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $5,000 | +66.7% | 239 | +9.1% | 0.00% | +50.0% |
| Q4 2020 | $3,000 | 0.0% | 219 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $3,000 | – | 219 | +1360.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 15 | -96.0% | 0.00% | -100.0% |
| Q3 2019 | $7,000 | -22.2% | 375 | -8.3% | 0.01% | -16.7% |
| Q2 2019 | $9,000 | +12.5% | 409 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $8,000 | -20.0% | 409 | -3.3% | 0.01% | +20.0% |
| Q3 2018 | $10,000 | – | 423 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
| Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
| Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
| Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
| DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
| Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
| AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
| ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |